Waszak, Sebastian M <br/><br/>
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.  [electronic resource] 

 -  The Lancet. Oncology  06 2018 
 - 785-798 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(18)30242-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Biomarkers, Tumor--genetics<br/>Cerebellar Neoplasms--genetics<br/>Child<br/>Child, Preschool<br/>DNA Methylation<br/>DNA Mutational Analysis<br/>Female<br/>Gene Expression Profiling<br/>Genetic Predisposition to Disease<br/>Genetic Testing--methods<br/>Germ-Line Mutation<br/>Heredity<br/>Humans<br/>Infant<br/>Male<br/>Medulloblastoma--genetics<br/>Models, Genetic<br/>Pedigree<br/>Phenotype<br/>Predictive Value of Tests<br/>Progression-Free Survival<br/>Prospective Studies<br/>Reproducibility of Results<br/>Retrospective Studies<br/>Risk Factors<br/>Transcriptome<br/>Exome Sequencing<br/>Young Adult